Video Shorts

1:02
Raising Awareness for PD-L1 Testing for Head and Neck Cancer
2 months ago
by
Fangdi Sun, MD

0:36
Safely Incorporating Integrative Medicine Into Breast Oncology
2 months ago
by
Lillian Rodich, MSPAS, MPH

0:24
Examining the Potential Role of ctDNA-Guided Therapy in RCC
2 months ago
by
Taigo Kato, MD, PhD

0:44
Highlighting the Importance of PD-L1 Testing for Head and Neck Cancer
2 months ago
by
Ranee Mehra, MD

1:13
Spotlighting the Future of Triple-Negative Breast Cancer Management
2 months ago
by
Rena D. Callahan, MD

0:41
Targeting CALR Mutations in Myeloproliferative Neoplasms
2 months ago

2:51
Recapping the Most Important Data and Developments From SGO 2026!
2 months ago
by
Caroline Seymour(+2 more)

0:40
Evaluating the Landscape of Radioligand Therapies in Prostate Cancer
2 months ago
by
Jeff Michalski, MD, MBA, FASTRO

1:13
Significance of the KEYNOTE-B96 Results in Recurrent PROC
2 months ago
by
Bradley Monk, MD, FACOG, FACS

0:35
Final OS Data From the ROSELLA Trial in PROC
2 months ago
by
Alexander B. Olawaiye, MD

0:39
Gathering Expert Insights at SGO 2026!
2 months ago
by
Caroline Seymour(+1 more)

0:28
Data From the CARE Trial in Recurrent/Advanced Endometrial Cancer
2 months ago
by
Yang Sun, MD

0:26
Efficacy of Pamirtecan in HER2-Expressing Endometrial Cancer
2 months ago
by
Bhavana Pothuri, MD

0:27
Using Social Media to Build a Presence in Gynecologic Oncology
2 months ago
by
Megan Hutchcraft, MD

0:27
Testing the Bispecific Antibody REGN5668 in Gynecologic Cancers
2 months ago
by
Roisin E. O'Cearbhaill, MD

4:19
OncLive News Roundup for the Week of 4/5
2 months ago
by
Chris Ryan(+1 more)

0:38
Preparing for SGO 2026 in Puerto Rico!
2 months ago
by
Caroline Seymour(+1 more)

0:39
Initiating Productive Conversations About Weight Gain During Breast Cancer Treatment
2 months ago
by
Patricia Jakel, MSN

1:05
When Is IM Nailing vs Endoprosthetic Reconstruction the Right Choice in Metastatic Bone Disease?
2 months ago
by
R. Lor Randall, MD, FACS

0:30
Why Real-World Data Are Critical for Targeted Therapy Use in Cholangiocarcinoma
2 months ago
by
Lipika Goyal, MD

0:30
Unpacking Real-World Use of Relugolix in Prostate Cancer
2 months ago
by
Rana R. McKay, MD

0:34
Breaking Down the Basics of Orca-T and its Development
2 months ago
by
Sagar Patel, MD

1:00
Molecular Profiling Is Reshaping Treatment in Cholangiocarcinoma
2 months ago
by
Lipika Goyal, MD

0:55
Unpacking the Significance of the FDA Approval of Brexu-Cel for MCL
2 months ago
by
Lore Gruenbaum, PhD

0:57
Delineating Adjuvant Radiation Therapy Modalities for Breast Cancer
2 months ago
by
Meghan R. Flanagan, MD, MPH

1:11
The Evolution of Follicular Lymphoma Management
2 months ago
by
Amitkumar Mehta, MD

3:42
OncLive News Roundup for the Week of 3/29
2 months ago
by
Chris Ryan(+1 more)

0:29
Investigating ADT Plus Pembrolizumab in Salivary Gland Carcinoma
2 months ago
by
Manish R. Patel, DO

1:59
Unpacking the Meaning of Microplastics in Prostate Cancer Samples
2 months ago
by
Stacy Loeb, MD

0:51
Examining Real-World Outcomes With Lutetium Lu 177 Vipivotide Tetraxetan
2 months ago
by
Mohammad Arfat Ganiyani, MBBS
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
3
GU Cancer Experts Highlight the Most Impactful and Discussion-Worthy Data Presented at ASCO 2026
4
Subcutaneous Isatuximab Administered Via OBI Approved in EU for Multiple Myeloma
5
